258 related articles for article (PubMed ID: 9312997)
41. [Radiofrequency ablation of supraventricular tachycardias].
García Bolao I; Brugada J
Rev Med Univ Navarra; 1998; 42(1):34-41. PubMed ID: 10420955
[TBL] [Abstract][Full Text] [Related]
42. Dose related efficacy of adenosine triphosphate in spontaneous supraventricular tachyarrhythmias.
Moro C; Lorio N; Nuñez A; Martinez J; Novo L; Aguilera M; Madrid AH
Int J Cardiol; 1989 Nov; 25(2):207-12. PubMed ID: 2807609
[TBL] [Abstract][Full Text] [Related]
43. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia.
Atalar E; Haznedaroglu IC; Acil T; Ozer N; Kilic H; Ovunc K; Aksoyek S; Nazli N; Kes S; Kabakçi G; Kirazli S; Ozmen F
Platelets; 2003; 14(7-8):407-11. PubMed ID: 14713509
[TBL] [Abstract][Full Text] [Related]
44. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
Dorian P; Naccarelli GV; Coumel P; Hohnloser SH; Maser MJ
Am J Cardiol; 1996 Jan; 77(3):89A-95A. PubMed ID: 8607397
[TBL] [Abstract][Full Text] [Related]
45. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.
Bhandari AK; Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Cullen MT; Hawkinson RW; Pritchett EL
Am Heart J; 1992 Aug; 124(2):381-6. PubMed ID: 1636582
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of intravenous adenosine in treatment of paroxysmal supraventricular tachycardia in the local population.
Seet CM
Singapore Med J; 1997 Dec; 38(12):525-8. PubMed ID: 9550919
[TBL] [Abstract][Full Text] [Related]
47. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.
Page RL; Wilkinson WE; Clair WK; McCarthy EA; Pritchett EL
Circulation; 1994 Jan; 89(1):224-7. PubMed ID: 8281651
[TBL] [Abstract][Full Text] [Related]
48. Relationships between adrenal insufficiency and cardiovascular outcomes in patients with atrial fibrillation, atrial flutter and paroxysmal supraventricular tachycardia.
Abdallah N; Mohamoud A; Kearns A; Abdallah M; Linzer M
Curr Probl Cardiol; 2024 Aug; 49(8):102641. PubMed ID: 38754754
[TBL] [Abstract][Full Text] [Related]
49. Pre-excited atrial fibrillation triggered by intravenous adenosine: a commonly used drug with potentially life-threatening adverse effects.
Turley AJ; Murray S; Thambyrajah J
Emerg Med J; 2008 Jan; 25(1):46-8. PubMed ID: 18156545
[TBL] [Abstract][Full Text] [Related]
50. Adenosine-induced cardiopulmonary arrest in a patient with paroxysmal supraventricular tachycardia--a response.
Jenkins NS; Knights M; Eickmann C; Payne M
Am J Emerg Med; 2010 May; 28(4):526; author reply 526-7. PubMed ID: 20466244
[No Abstract] [Full Text] [Related]
51. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.
Rosenbaum MB; Chiale PA; Ryba D; Elizari MV
Am J Cardiol; 1974 Aug; 34(2):215-23. PubMed ID: 4843156
[No Abstract] [Full Text] [Related]
52. Surgical therapy for patients with supraventricular tachycardia.
Ferguson TB; Cox JL
Cardiol Clin; 1990 Aug; 8(3):535-55. PubMed ID: 2205389
[TBL] [Abstract][Full Text] [Related]
53. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
Gambhir DS; Bhargava M; Arora R; Khalilullah M
Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
[TBL] [Abstract][Full Text] [Related]
54. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of atrial fibrillation in patients with history of paroxysmal supraventricular tachycardia.
Khachab H; Brembilla-Perrot B
Int J Cardiol; 2013 Jun; 166(1):221-4. PubMed ID: 22078397
[TBL] [Abstract][Full Text] [Related]
56. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
DiMarco JP; Miles W; Akhtar M; Milstein S; Sharma AD; Platia E; McGovern B; Scheinman MM; Govier WC
Ann Intern Med; 1990 Jul; 113(2):104-10. PubMed ID: 2193560
[TBL] [Abstract][Full Text] [Related]
57. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
[TBL] [Abstract][Full Text] [Related]
58. [Clinical contribution in the treatment of paroxysmal tachycardia].
Tassone F
Minerva Med; 1974 Sep; 65(60):3140-6. PubMed ID: 4153900
[No Abstract] [Full Text] [Related]
59. Propafenone in Wolff-Parkinson-White syndrome at risk.
Santinelli V; Turco P; De Paola M; Smimmo D; Giasi M; Santinelli C; Chiariello M; Condorelli M
Cardiovasc Drugs Ther; 1990 Jun; 4(3):681-5. PubMed ID: 2076378
[TBL] [Abstract][Full Text] [Related]
60. [The diagnostic value of esophageal ECG and transesophageal atrial stimulation in paroxysmal supraventricular tachycardia].
Pehrson SM; Blomström P
Ugeskr Laeger; 1991 Nov; 153(48):3403-7. PubMed ID: 1957408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
